Meet Emerald Clinical’s Experts
at DIA China 2026
Booth J15, Shanghai, May 14–16, 2026
Book a Meeting with Us
Come and visit us at booth J15 and meet the team. Our experts will be on hand to share end-to-end clinical trial solutions across all phases, offering Phase I-IV and real-world studies.
Are you looking for a CRO that combines global reach with true regional depth?
As a full-service CRO with over 1,000 employees across China, EMEA, and the Americas. We work with top investigators and KOLs to advance clinical development – from early‑phase research to specialized programs in renal, oncology, autoimmune, and cardiometabolic disorders.
With deep roots in Asia Pacific, we know the regulatory, site, and cultural details that can make or break a trial. In China alone, we partner with over 2,800 research centers and 15,000 medical experts, including strategic relationships with more than 80 institutions – getting sites up and running in three months on average. Whether you’re entering Asia from global markets or taking a local biotech worldwide, we run synchronized, end‑to‑end development across our global footprint, with consistent quality and full regulatory compliance at every site.
Onsite Expert Consultations
Head of Clinical Regulatory Affairs, Will Chen, and Head of Clinical Medical Affairs, Yapeng Zhao, will be at Booth J15 on May 14 – ready to answer your questions on submission plans, cross‑regional submissions, medical monitoring, and Asia‑Pacific clinical operations.
Here is the schedule for the day:
Session 2 | May 14, 14:00 – 16:00
Yapeng Zhao – Head of Clinical Medical Affairs, Hongyi Clinical
What she actually helps sponsors with:
- Clinical development strategy for Asia Pacific
- Protocol design that keeps sites and patients from dropping out
- Medical monitoring – when to step in, when to step back
If your study is stuck at enrollment or site feedback is all over the place, she’s the one to talk to.
Session 1 | May 14, 09:00 – 11:00
Will Chen – Head of Clinical Regulatory Affairs, Hongyi Clinical
What he actually helps sponsors with:
- IND/NDA strategies that won’t blow your timeline
- Cross‑regional submissions (China + US + EU without losing your mind)
- Regulatory risk – what can be fixed early, what can’t
Bring your submission plan. He’ll point out one thing you can improve tomorrow.
What we actually do well
Emerald Clinical, with end-to-end clinical development expertise rooted in the Asia Pacific region and a seamless global footprint spanning China, EMEA, and the Americas. We are committed to providing life-changing treatments to patients worldwide.
Renal – From CKD to rare glomerular disorders, our renal CRO services provide agile, patient‑centric solutions that fuel recruitment, prioritize safety, and deliver change for patients worldwide.
Oncology – From highly prevalent to rare cancers, our oncology CRO services deliver agile, patient‑first solutions that drive recruitment, prioritize safety, and build a strong foundation for trial success.
Autoimmune – From common to rare autoimmune conditions, our science-driven, patient-first solutions prioritise safety and accelerate recruitment. We provide services from the early phase to post-marketing for small molecules and biologics.
Book a Meeting with Us
How we have helped our clients
Meet our Team
Learn more about why we are a global leader in clinical research.
Cory Hu
Yanqi Gao
